borderline ovarian tumors
MANAGEMENT OF BORDERLINE OVARIAN TUMORS
5
<p>The Diagnosis, Treatment, Prognosis and Molecular Pathology of Borderline Ovarian Tumors: Current Status and Perspectives</p>
9
Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study
8
Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors
9
Utility of Frozen Section in the Evaluation of Borderline Ovarian Tumors: A Single Institution Experience
5
Identification of factors that impact recurrence in patients with borderline ovarian tumors
8
Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience
8
<p>Ultraconservative, Fertility Sparing Treatment of Bilateral Borderline Ovarian Tumors: A Case Report of a 26-Year-Old, 0-Gravida with an Endometrioid Borderline Ovarian Tumor of the Right Ovary and a Sero-Mucinous Borderline Ovarian Tumor of the Left Ovary and a Review of the Literature</p>
11
Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers
10
Genomic aberrations in borderline ovarian tumors
9
Does preoperative neutrophil to lymphocyte or platelet to lymphocyte ratios have a role in predicting borderline ovarian tumors?
6
<p>KNDC1 Is a Predictive Marker of Malignant Transformation in Borderline Ovarian Tumors</p>
10
Conservative management in young patients with borderline and malignant ovarian tumors: outcomes and pregnancies
6
Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways
7
Download Download PDF
9
Intraoperative frozen section analysis of ovarian tumors: a 11-year review of accuracy with clinicopathological correlation in a Hong Kong Regional hospital
7
Download Download PDF
8
MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation
10
Serum Calprotectin and Prealbumin Levels among Ovarian Cancer Patients Aged 30 45 Years
10
EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma
7